← All stocks

TAKEDA PHARMACEUTICAL CO LTD

TAK Net selling
CIK 0001395064 #575 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$3.39M
$2.51M on a plan · $0.00 straight out of an exercise
Sold at will
$875.40K
2 of 4 sales
Net
−$3.39M
−$875.40K against sales at will

By person

25 insiders · 4 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Plump Andrew Stewart
President, R&D
$2.51M (2) scheduled
−$2.51M
1,173,690
$21.76M
+3.2%
Duprey Lauren Rusckowski
Chief Transformation Officer
$640.28K (1)
−$640.28K
191,522
$3.55M
+13.7%
Greenway Nicola Deidre Petal
Chief Human Resources Officer
$235.12K (1)
−$235.12K
40,049
$742.51K
−44.2%
Weber Christophe Pierre
President and CEO
1,433,003
$26.57M
+20.5%
Kim Julie So-Young
President and CEO
414,289
$7.68M
+27.6%
Platford Giles Richard
President, IBU
315,838
$5.86M
+40.2%
Bitetti Teresa Marie
President, OBU
252,010
$4.67M
+30.5%
Furney Natalie Anne Marie
Global General Counsel
204,298
$3.79M
+6.8%
Pacheco Rhonda Janice
President, U.S. Business Unit
182,507
$3.38M
+22.3%
Pignagnoli Agosti Marcello
Head, Strat. & Port. Dev
176,977
$3.28M
+22.4%
Ricci Gabriele
Chief Data & Tech. Officer
171,654
$3.18M
+38.3%
Farajallah Awny Samaan Botros
Chief Medical Officer
116,177
$2.15M
+3.2%
Ibrahim Ramy Riad Ahmed
President, PDT BU
102,588
$1.90M
+21.0%
Furuta Milano
Chief Financial Officer
70,200
$1.30M
+40.1%
Shannon Elaine Mary
Pres., Global Supply & Quality
67,311
$1.25M
+9.3%
Smoter Jennifer Marie
Chief Comm. & Gov. Officer
18,808
$348.70K
Iijima Masami
Director
14,601
$270.70K
+14.1%
GILLIS STEVEN
Director
10,400
$192.82K
+57.6%
MARAGANORE JOHN
Director
10,400
$192.82K
+57.6%
Reed Kimberly A.
Director
10,400
$192.82K
+57.6%
Tsusaka Miki
Director
8,200
$152.03K
+28.1%
BROUSSARD BRUCE D
Director
4,595
$85.19K
+478.0%
Miyabashira Asuka
President, Japan Pharma B.U.
4,500
$83.43K
+50.0%
Stoffels Paulus
Director
3,800
$70.45K
Kimura Koichiro
Director
1,800
$33.37K

No percentages here. TAKEDA PHARMACEUTICAL CO LTD reports its share count only per share class, which the XBRL frames API does not carry.

Insider
Date
Role
Action
Shares
Price
Amount
Duprey Lauren Rusckowski
14 Sep 2026
Chief Transformation Officer
Sell
34,535
$18.54
$640.28K
Plump Andrew Stewart
2 Sep 2026
President, R&D
Sold on a plan indirect
116,191
$18.49
$2.15M
Plump Andrew Stewart
19 Aug 2026
President, R&D
Sold on a plan indirect
19,651
$18.49
$363.35K
Greenway Nicola Deidre Petal
18 Aug 2026
Chief Human Resources Officer
Sell
12,980
$18.11
$235.12K

What was left out

Form 4 filings counted 4
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 0
History held since 21 Mar 2018